Patients With Severe TrIcuspid Regurgitation After triCvALve System Implantation

International Registry to collect patients with severe TR undergoing TricValve implantation from multiple Italian and European centers, aimed at: * Assessing the effect of TricValve implantation on cardiovascular and all-cause mortality, HF rehospitalization, renal function, functional capacity and quality of life. * Clarifying the haemodynamic effects of TricValve implantation and investigating their pathophysiological implications.

NCT Number	NCT05820516
Lead Sponsor	Azienda Ospedaliero, Universitaria Pisana Collaborators: Azienda Ospedaliera Universitaria Integrata Verona, Casa di Cura Pierangeli, Pescara, Fondazione Toscana Gabriele Monasterio, IRCCS San Raffaele, Humanitas Research Hospital IRCCS, Rozzano-Milan, Fondazione Poliambulanza Hospital (Brescia, Italy), IRCCS Casa Sollievo della Sofferenza, Ospedale Monaldi di Napoli, Ospedale San Bortolo di Vicenza, Azienda Ospedaliera San Camillo Forlanini, Azienda Policlinico Umberto I, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Asst Degli Spedali Civili Di Brescia, Ospedale Santa Corona di Pietra Ligure, Centro Cardiologico Monzino, Maria SS Addolorata di Eboli, Ospedale Polispecialistico Humanitas Gavazzeni, Bergamo, Niguarda Hospital, A.O. Ospedale Papa Giovanni XXIII, Azienda Ospedaliero-Universitaria Careggi, IRCCS Multimedica, Ospedale Miulli, Acquaviva delle Fonti, Azienda Ospedaliera "Sant'Andrea", I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio, IRCCS ISMETT Palermo, I.R.C.C.S. Policlinico San Donato, San Donato Milanese, Italy
Conditions	Severe Tricuspid Valve Regurgitation
Enrollment	100 participants
Start Date	2025-02-01
Primary Completion	2026-12 (estimated)
Study Completion	2027-05 (estimated)
Updated on ClinicalTrials.gov	2026-05-11